Purple Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Purple Biotech and other ETFs, options, and stocks.About PPBT
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3.
CEOGil Efron
CEOGil Efron
Employees10
Employees10
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded1968
Founded1968
Employees10
Employees10
PPBT Key Statistics
Market cap11.52M
Market cap11.52M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume125.79K
Average volume125.79K
High today$1.84
High today$1.84
Low today$1.33
Low today$1.33
Open price$1.53
Open price$1.53
Volume974.89K
Volume974.89K
52 Week high$24.00
52 Week high$24.00
52 Week low$1.16
52 Week low$1.16
PPBT News
TipRanks 10h
Purple Biotech Unveils August 2026 Corporate Update on Tri-Specific Immuno-Oncology PlatformUnlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
TipRanks 3d
Purple Biotech Posts Q2 2026 Results as IM1240 Preclinical Data Strengthen Immunotherapy Platform - TipRanks...
TipRanks 4d
Purple Biotech price target lowered to $17 from $30 at H.C. WainwrightH.C. Wainwright lowered the firm’s price target on Purple Biotech (PPBT) to $17 from $30 and keeps a Buy rating on the shares. The firm cites the company’s “low...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.